Invitrogen™ Human CD38 ELISA Kit

Ref.: BL-RE-093819Manufacturer ref.: EH89RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human CD38 quantitates human CD38 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD38.

Accession number
2 '-phospho-ADP-ribosyl cyclase ; 2 '-phospho-ADP-ribosyl cyclase/2 '-phospho-cyclique-ADP-ribose transférase ; 2 '-phospho-cyclique-ADP-ribose transférase ; ADPRC 1 ; ADPRC1 ; ADP-ribosyl cyclase 1 ; ADP-ribosyl cyclase/ADP-ribose hydrolase 1 cyclique ; cADPR hydrolase 1 ; Cd38 ; antigène CD38 ; antigène CD38 (ADP-ribosyl cyclase / ADP-ribose hydrolase cyclique) ; antigène CD38 (p45) ; antigène CD38 p45 ; molécule CD38 ; CD38H ; Cd38-rs1 ; groupe de différenciation 38 ; ADP-ribose cyclique hydrolase 1 ; ecto-nicotinamide adénine dinucléotide glycohydrolase ; I-19 ; NAD(+) nucléosidase ; NAD+ nucléosidase ; antigène NIM-R5 ; T10
Dose range
0.41 to 100 ng/ml
Sensitivity of the dosage
0.41 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human CD38 quantitates human CD38 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD38.

Human CD38 quantitates human CD38 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD38.

CD38 (NAD+ glycohydrolase) is a II transmembrane glycoprotein capable of inducing activation, proliferation and differentiation of mature lymphocytes and governing myeloid and lymphoid stem cell apoptosis. CD38 works as a multi-catalytic ectoenzyme serving as a cyclase, cyclic hydrolase and possibly NAD+ glycohydrolase or as a cell surface receptor. anti-CD38 antibodies are useful for subtyping lymphomas and leukemias, for detecting plasma cells (i.e., identifying myelomas) and as an activated B and T cell marker. CD38 contributes to cell adhesion, signal transduction and calcium signaling. In addition, CD38 is expressed at high levels in the pancreas, liver, kidney, malignant lymphoma, and neuroblastoma. Diseases associated with CD38 dysfunction include chronic lymphoid leukemia and Richter's syndrome.

Sensitivity

Sensitivity of dosage: 0.41 ng/ml.

Measurement range

Dose range: 0.41 to 100 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: CD38.

Samples

Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17195319
Specifications
Accession number2 '-phospho-ADP-ribosyl cyclase; 2 '-phospho-ADP-ribosyl cyclase/2 '-phospho-cyclic-ADP-ribose transferase; 2 '-phosphocyclic-ADP-ribose transferase; ADPRC 1; ADPRC1; ADP-ribosyl cyclase 1; ADP-ribosyl cyclase/ADP-ribose hydrolase 1 cyclic ; cADPR hydrolase 1 ; Cd38; CD38 antigen; year
Dose range0.41 to 100 ng/ml
Sensitivity of the dosage0.41 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P28907
Gene symbol(s)CD38
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetCD38
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; plasma, 50 µl; supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH89RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.